AstraZeneca Tezspire approved for self administration in US with new pre filled pen Ruchika Sharma3 Feb 2023 12:15 PM ISTThe Tezspire pre-filled pen enables patients and caregivers to self-administer the medicine at home or in clinic via a simple process.
USFDA withdraws emergency use authorization for AstraZeneca COVID 19 treatment Evusheld Ruchika Sharma27 Jan 2023 4:42 PM ISTAstraZeneca said it was informed that the agency will decide about reinstating authorization of Evusheld if the prevalence of resistant variants in...
Alembic Pharma bags USFDA nod for mantle cell lymphoma drug Acalabrutinib Ruchika Sharma19 Jan 2023 3:15 PM ISTAcalabrutinib Capsules are indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy...
Health Ministry shocker in RTI reply: CDSCO, ICMR admit to multiple side effects of Covid-19 jabs Farhat Nasim17 Jan 2023 2:04 PM ISTNew Delhi: In a shocking response to an RTI query, the Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research...
AstraZeneca concludes acquisition of Neogene Therapeutics Ruchika Sharma17 Jan 2023 1:15 PM ISTUK: AstraZeneca has completed the acquisition of Neogene Therapeutics Inc.. Neogene will operate as a wholly-owned subsidiary of AstraZeneca, with...
Asthma treatment: AstraZeneca Tezspire approved for self-administration in EU in new pre-filled pen Ruchika Sharma15 Jan 2023 9:00 AM ISTTezspire will be available as a fixed-dose 210mg subcutaneous injection via a pre-filled, single-use auto-injector (the Tezspire pre-filled pen), in...
AstraZeneca to acquire CinCor Pharma in USD 1.8 billion deal Ruchika Sharma9 Jan 2023 4:35 PM ISTWaltham: CinCor Pharma, Inc. today announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to...
USFDA accepts AstraZeneca’s BLA for Nirsevimab for prevention of RSV lower respiratory tract disease Ruchika Sharma7 Jan 2023 10:00 AM ISTRSV is a very contagious virus that can lead to serious respiratory illness, according to the Centers for Disease Control and Prevention.
AstraZeneca Calquence gets Japenese nod for treatment-naïve chronic lymphocytic leukaemia Ruchika Sharma1 Jan 2023 10:00 AM ISTCalquence (acalabrutinib) is a next-generation, selective inhibitor of BTK.
AstraZeneca gets CDSCO panel nod to study anticancer drug Datopotamab deruxtecan Dr. Divya Colin31 Dec 2022 5:45 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
GSK, Sanofi, Pfizer and other drugmakers plan to raise prices on at least 350 drugs in US in January Ruchika Sharma31 Dec 2022 1:15 PM ISTTo date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira...
AstraZeneca gets Japanese approval for Imfinzi, Imjudo to treat 3 types of cancer Ruchika Sharma28 Dec 2022 11:30 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
